Wang Zhengrong, Xu Yuqing, Sun Yixi, Wang Shuang, Dong Minyue
School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, China.
Guizhou Prenatal Diagnosis Center, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Front Pediatr. 2023 Jan 10;10:1062900. doi: 10.3389/fped.2022.1062900. eCollection 2022.
Glanzmann thrombasthenia (GT) is a rare inherited disease characterized by mucocutaneous bleeding due to the abnormalities in quantity or quality of platelet membrane GP IIb (CD41) or GP IIIa (CD61). GP IIb and GP IIIa are encoded by the and genes, respectively. Herein, we described a 7-year-old Chinese boy of the consanguineous couple who was diagnosed with GT based on the typical clinical manifestations, absence of blood clot retraction and the reduced expression of CD41 and CD61 in platelets. A homozygous silent variant c.1431C > T (p. G477=) of the gene was identified by the Whole-exome sequencing and confirmed by Sanger sequencing. The variant was predicted to affect the splicing. RT-PCR and sequencing revealed that the variant caused a deletion of 95 base pairs and frameshift, and subsequently created a premature stop codon in exon 10 of (p. G477Afs*30). It was indicated that the variant c.1431C > T (p. G477=) of was the cause for Glanzmann thrombasthenia. Our findings expanded the mutation spectrum and provided the information for the genetic counseling, prenatal diagnosis and preimplantation genetic testing (PGT).
血小板无力症(GT)是一种罕见的遗传性疾病,其特征是由于血小板膜糖蛋白IIb(CD41)或糖蛋白IIIa(CD61)的数量或质量异常而导致皮肤黏膜出血。糖蛋白IIb和糖蛋白IIIa分别由 和 基因编码。在此,我们描述了一名7岁的中国男孩,其父母为近亲结婚,根据典型的临床表现、无血块退缩以及血小板中CD41和CD61表达降低,被诊断为血小板无力症。通过全外显子组测序鉴定出 基因的一个纯合沉默变异c.1431C>T(p.G477=),并通过桑格测序进行了确认。该变异预计会影响剪接。逆转录聚合酶链反应(RT-PCR)和测序显示,该变异导致95个碱基对的缺失和移码,随后在 基因的第10外显子中产生了一个提前终止密码子(p.G477Afs*30)。结果表明, 基因的变异c.1431C>T(p.G477=)是血小板无力症的病因。我们的研究结果扩展了突变谱,并为遗传咨询、产前诊断和植入前基因检测(PGT)提供了信息。